Poll Results

June 2021 Question of the Month

If COVID vaccination in children less than 12 years old is authorized this fall, will you vaccinate your children?

Yes: 18%

No: 59%

Undecided: 24%

May 2021 Question of the Month

How do you expect the new Pharmacist job market to look in the coming year?

More competitive: 71%

Less competitive: 6%

Same / no change: 24%

April 2021 Question of the Month

Is the pharmacy industry overall ready for the transition to UDI by the deadline?

All affected segments of the industry will be ready: 0.0%

Many segments of the industry will be ready with challenges: 0.0%

Old and new identifiers found in the marketplace for the same device will create confusion: 0.0%

Submitting claims for devices will be difficult during the transition:66.7%

Reimbursement payments for devices will be adversely affected: 0.0%

Many segments will not be ready making it difficult to dispense devices: 33.3%

I don’t have insight on this issue: 0.0%

March 2021 Question of the Month

How will the number of FDA drug approvals change in 2021 compared with 2020 due to the pandemic?

Fewer drug approvals in 2021 than 2020: 57.1%

About the same in 2021 as 2020: 28.6%

More drug approvals in 2021 than 2020: 14.3%

February 2021 Question of the Month Results

What will be the greatest limitation(s) in the COVID19 vaccine rollout in the US?

Patient ability to navigate the entire process:  26.32%

Patient acceptance of vaccine:  21.05%

Distribution/Administration:  21.05%

Vaccine supply:  15.79%

Procedural differences from state to state:  10.53%

Systems used to set up vaccination appointments:  5.26%

Proper interpretation of the rules for each phase:  0.00%

January 2021 Question of the Month

2022 or later: 62.5%

December 2020 Question of the Month

How will Amazon Pharmacy impact the pharmacy market in the next 5 years?

Competitive force influencing incumbents: 66.7%

Disruptive force: 25%

Market participant, no disruption: 8.3%

No longer participating: 0%

November 2020 Question of the Month

How will hospital and insurance plan price transparency impact patient costs?

Patients won’t notice: 40%

No impact: 20%

Increase patient costs: 20%

Decrease patient costs: 20%

October 2020 Question of the Month

What change do you most expect to see in the 340B program in the next year?

Reduced drug sales at 340B prices: 60%

Legislative changes to 340B program: 20%

HRSA lawsuit challenging 340B sales limitations by manufacturers: 20%

Shifting drug sales to 340B supportive manufacturers: 0%

 

September 2020 Question of the Month

Many industry conferences have been cancelled or shifted online due to COVID-19. How are you staying connected to industry colleagues?

Scheduling regular calls or online meetings: 54.5%

Participating in virtual conferences: 9.1%

Social media: 9.1%

All of the above: 27.3%

None of the above: 0%